Primary outcome
adherence failure of hormone therapy, failure of hormone therapy, breast cancer
BREAST CANCER
The main objective is to evaluate the benefit of the WEBAPPAC web-application on patient adherence to adjuvant hormone therapy for breast cancer 18 months after treatment start.The primary endpoint of the study is the proportion of patients with adherence failure of hormone therapy within 18 months after treatment start, in each arm. Adherence failure of hormone therapy will be defined by at least one of the following items:
Adherence score less than 6 on the 8-item Morisky questionnaire (MMSA8) [Treatment discontinuation since at least one month, documented in the patient’s adherence notebook;Absence of hormone therapy dispensation for at least one month, documented on the hormone therapy prescription, with traceability of each dispensation noted on the prescription;Permanent discontinuation of hormone therapy as declared by the patient at the 18-month follow-up medical consultation.